New hope for hard-to-treat colon cancer: drug duo tested in clinical trial
NCT ID NCT05990543
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This study tests a combination of two drugs, nelmastobart and capecitabine, in people with advanced colorectal cancer that no longer responds to or cannot tolerate standard chemotherapies. The goal is to see if this new combo is safe and can help control the cancer. About 59 adults with recurrent or metastatic colorectal cancer are participating.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Korea University Medical Center 73, Goryeodae-ro, Seongbuk-gu
Seoul, Seoul, 02841, South Korea
Conditions
Explore the condition pages connected to this study.